In 2024, there will be over 2 million new cancer diagnoses, according to the American Cancer Society. But as cancer incidence and the cost of cancer both continue to increase at alarming rates, so do the number of technologies that emerge set to redefine how cancer is detected, treated, and monitored. With so many companies offering point solutions to support various points of care, it can be very difficult to understand how each test or service fits within the broader context of a complete, population-approach to cancer.